177 related articles for article (PubMed ID: 16869748)
41. A specific gene expression signature for visceral organ metastasis in breast cancer.
Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive epigenetic analyses reveal master regulators driving lung metastasis of breast cancer.
Li K; Xu C; Du Y; Junaid M; Kaushik AC; Wei DQ
J Cell Mol Med; 2019 Aug; 23(8):5415-5431. PubMed ID: 31215771
[TBL] [Abstract][Full Text] [Related]
43. Establishment of a novel orthotopic model of breast cancer metastasis to the lung.
Guo W; Zhang S; Liu S
Oncol Rep; 2015 Jun; 33(6):2992-8. PubMed ID: 25963127
[TBL] [Abstract][Full Text] [Related]
44. Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus.
Gu B; España L; Méndez O; Torregrosa A; Sierra A
Carcinogenesis; 2004 Dec; 25(12):2293-301. PubMed ID: 15347599
[TBL] [Abstract][Full Text] [Related]
45. Causal Bayesian gene networks associated with bone, brain and lung metastasis of breast cancer.
Park SB; Hwang KT; Chung CK; Roy D; Yoo C
Clin Exp Metastasis; 2020 Dec; 37(6):657-674. PubMed ID: 33083937
[TBL] [Abstract][Full Text] [Related]
46. Breast cancer metastasis-associated genes: role in tumour progression to the metastatic state.
Nicolson GL
Biochem Soc Symp; 1998; 63():231-43. PubMed ID: 9513727
[TBL] [Abstract][Full Text] [Related]
47. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.
Perurena N; Zandueta C; Martínez-Canarias S; Moreno H; Vicent S; Almeida AS; Guruceaga E; Gomis RR; Santisteban M; Egeblad M; Hermida J; Lecanda F
J Hematol Oncol; 2017 Jan; 10(1):23. PubMed ID: 28103946
[TBL] [Abstract][Full Text] [Related]
48. Transcriptomic analysis identifies organ-specific metastasis genes and pathways across different primary sites.
Zhang L; Fan M; Napolitano F; Gao X; Xu Y; Li L
J Transl Med; 2021 Jan; 19(1):31. PubMed ID: 33413400
[TBL] [Abstract][Full Text] [Related]
49. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
Kluger HM; Chelouche Lev D; Kluger Y; McCarthy MM; Kiriakova G; Camp RL; Rimm DL; Price JE
Cancer Res; 2005 Jul; 65(13):5578-87. PubMed ID: 15994930
[TBL] [Abstract][Full Text] [Related]
50. Expression of Cadherin-17 Promotes Metastasis in a Highly Bone Marrow Metastatic Murine Breast Cancer Model.
Okada T; Kurabayashi A; Akimitsu N; Furihata M
Biomed Res Int; 2017; 2017():8494286. PubMed ID: 28197418
[TBL] [Abstract][Full Text] [Related]
51. Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation.
Tester AM; Sharp JA; Dhanesuan N; Waltham M; Thompson EW
Clin Exp Metastasis; 2002; 19(5):377-83. PubMed ID: 12198765
[TBL] [Abstract][Full Text] [Related]
52. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
[TBL] [Abstract][Full Text] [Related]
53. Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach.
Tomida S; Yanagisawa K; Koshikawa K; Yatabe Y; Mitsudomi T; Osada H; Takahashi T
Oncogene; 2007 Jul; 26(31):4600-8. PubMed ID: 17260014
[TBL] [Abstract][Full Text] [Related]
54. Microarrays bring new insights into understanding of breast cancer metastasis to bone.
Welch DR
Breast Cancer Res; 2004; 6(2):61-4. PubMed ID: 14979907
[TBL] [Abstract][Full Text] [Related]
55. Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone.
Wang L; Song L; Li J; Wang Y; Yang C; Kou X; Xiao B; Zhang W; Li L; Liu S; Wang J
Cancer Sci; 2019 Oct; 110(10):3157-3172. PubMed ID: 31432600
[TBL] [Abstract][Full Text] [Related]
56. Breast cancer bone metastasis: molecular basis of tissue tropism.
Kang Y
J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):379-80. PubMed ID: 15758269
[No Abstract] [Full Text] [Related]
57. Human tissue-specific microenvironment: an essential requirement for mouse models of breast cancer.
Xia TS; Wang J; Yin H; Ding Q; Zhang YF; Yang HW; Liu XA; Dong M; Du Q; Ling LJ; Zha XM; Fu W; Wang S
Oncol Rep; 2010 Jul; 24(1):203-11. PubMed ID: 20514463
[TBL] [Abstract][Full Text] [Related]
58. Metastasis suppressor genes: basic biology and potential clinical use.
Steeg PS; Ouatas T; Halverson D; Palmieri D; Salerno M
Clin Breast Cancer; 2003 Apr; 4(1):51-62. PubMed ID: 12744759
[TBL] [Abstract][Full Text] [Related]
59. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants.
Lu X; Kang Y
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9385-90. PubMed ID: 19458257
[TBL] [Abstract][Full Text] [Related]
60. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
